Governments of the world need to ensure the strengthening of health systems to be able to provide treatment, support and rehabilitation to improve long-term COVID-19 outcomes. In December 2020 ISARIC (the International Severe Acute Respiratory and emerging Infection Consortium), the research funders group GloPID-R (The Global Research Collaboration for Infectious Disease Preparedness) and global group, Long Covid Support, jointly organised a "Long Covid Forum" [[8]]. Coronavirus research, WHO R&D COVID-19 Research Agenda, ISARIC, Long Covid Support Group, Long Covid, GloPID-R Keywords: Long Covid; Coronavirus research; WHO R&D COVID-19 Research Agenda; GloPID-R; ISARIC; Long Covid Support Group EN Long Covid Coronavirus research WHO R&D COVID-19 Research Agenda GloPID-R ISARIC Long Covid Support Group 1 4 4 04/01/21 20210331 NES 210331 Background Coronavirus disease 2019 (COVID-19) can lead to a diverse range of clinical manifestations, ranging from an asymptomatic infection to an acute respiratory distress syndrome, and multiorgan failure with high mortality rates [[1]]. [Extracted from the article]